Preclinical Research Centre
Sri Balaji Vidyapeeth (SBV) has proven its commitment to biomedical research by facilitating drug discovery and regulatory services for industrial products including preclinical R&D pharm therapeutics, biotech, natural products, agrochemical and chemical industries. SBV has entered into a multi-crore joint venture with the Department of Biotechnology, Government of India to establish a new small Animal Research Facility for Preclinical Studies and Services named “Mahatma Gandhi Medical Preclinical Research Centre” (MGMPRC), located inside SBV Campus, Pillayarkuppam, Puducherry, India.
Thrust Area
Toxicology Screening
Pharmacological Studies
Disease models (Rodents/ Zebrafish)
Vision
MGMPRC is dedicated to supporting the R&D Pharma and scientific communities with high-quality data standards in Preclinical toxicology and Exploratory pharmacology.
Mission
MGMPRC is poised to serve regulatory services for the industrial and R&D needs of industries and researchers in both public and private sectors across the globe. MGMPRC’s extended research support includes end-to-end delivery of the program by providing consultancy, study designs, and the conduct of studies, as well as providing a scientific rationale for the findings of the study.
What we stand for
- Customer satisfaction by paying attention to their needs and going above and beyond what they anticipate.
- Developing affordable solutions to assist our clients in achieving their objectives.
- Delivering quality reports on time and with accuracy through the use of the best available tools and techniques.
- Assembling a crew of bright and knowledgeable personnel putting money into training and developing rewarding career opportunities.
- Acting morally in our economic and financial dealings.
- Showing courtesy to our clients, employees, and running ethical environmental policies.
